203 related articles for article (PubMed ID: 24549282)
1. Downregulation of microRNA-139 is associated with hepatocellular carcinoma risk and short-term survival.
Li T; Yin J; Yuan L; Wang S; Yang L; Du X; Lu J
Oncol Rep; 2014 Apr; 31(4):1699-706. PubMed ID: 24549282
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma.
Yu L; Zhang J; Guo X; Li Z; Zhang P
Cancer Epidemiol; 2014 Aug; 38(4):408-13. PubMed ID: 24923856
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma.
Shim JH; Kang HJ; Han S; Lee YJ; Lee SG; Yu E; Lee HC
J Gastroenterol Hepatol; 2014 Mar; 29(3):524-32. PubMed ID: 23981200
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
[TBL] [Abstract][Full Text] [Related]
5. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
6. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
7. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
Zheng J; Dong P; Gao S; Wang N; Yu F
Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma.
Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM
Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304
[TBL] [Abstract][Full Text] [Related]
10. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
[TBL] [Abstract][Full Text] [Related]
11. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
13. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
14. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
[TBL] [Abstract][Full Text] [Related]
15. A low level of GPR37 is associated with human hepatocellular carcinoma progression and poor patient survival.
Liu F; Zhu C; Huang X; Cai J; Wang H; Wang X; He S; Liu C; Yang X; Zhang Y; Zhang T
Pathol Res Pract; 2014 Dec; 210(12):885-92. PubMed ID: 25169131
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.
Tomimaru Y; Eguchi H; Nagano H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Tomokuni A; Takemasa I; Umeshita K; Kanto T; Doki Y; Mori M
J Hepatol; 2012 Jan; 56(1):167-75. PubMed ID: 21749846
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
18. Metastasis-related miR-185 is a potential prognostic biomarker for hepatocellular carcinoma in early stage.
Zhi Q; Zhu J; Guo X; He S; Xue X; Zhou J; Hu B; Li H; Chen S; Zhao H; Kuang Y
Biomed Pharmacother; 2013 Jun; 67(5):393-8. PubMed ID: 23648054
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma.
Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
